Genomma Lab stock pre-market at EUR 0.69 ahead of Xetra open
Published on 10/22/2026 at 07:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and agenda
- Genomma Lab develops, sells and markets branded pharmaceutical and personal-care products.
- The company's third-quarter earnings call is scheduled for October 22, 2026, at 1:00 p.m. ET.
- Genomma Lab stock trades pre-market at EUR 0.69 at 7:41 a.m. CEST at Lang & Schwarz on October 22, 2026.
Genomma Lab develops, sells and markets branded pharmaceutical and personal-care products in Mexico and internationally, earning revenue through product sales and distribution. At 7:41 a.m. CEST on October 22, 2026, Genomma Lab stock trades pre-market at EUR 0.69 at Lang & Schwarz.
Before the Xetra open
The bid is EUR 0.68 and the ask is EUR 0.71, a 4.35 percent spread that indicates thin pre-market trading. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Genomma Lab stock.
Business model and the day ahead
The company combines product development, consumer-oriented marketing and retail distribution to sell its branded health and personal-care products, according to the company release. Genomma Lab's third-quarter earnings call is scheduled for October 22, 2026, at 1:00 p.m. ET, according to the same release. Market context: Market report Latest market reports.
